Earnings Preview — 5182 total
PEDEVCO Corp. reports today with short sellers pulling back and borrowing costs easing — a setup that looks more relaxed than charged. The clearest signal heading into the print is what bears are not doing. Short…
Propanc Biopharma heads into its May 18 earnings release as one of the more volatile micro-cap biotechs on the Nasdaq calendar, with short interest surging and its stock price hitting new lows. The short interest story…
Fortress Biotech heads into its Q1 2026 print with one of the most elevated short positioning profiles among small-cap biotechs. Short sellers are heavily committed. At 14.6% of free float, short interest is material…
VolitionRx walks into today's Q1 2026 print with a dramatically altered short-seller landscape — one where a massive cover-down has reshaped the positioning story entirely. The most striking shift is in short interest.…
Lixte Biotechnology Holdings heads into its May 15 earnings report on the back of a 72% price surge over the past month — and with insiders who evidently share the enthusiasm. The most striking element of the…
Short sellers hold no meaningful grip on SCOR ahead of tonight's Q1 2026 results — and the lending market confirms it. Short interest is negligible at just 0.52% of the free float, with borrow availability running at…
Bio Green Med Solution, Inc. reports on May 18 with short sellers holding a relatively modest position — but the borrow market tells a more complicated story. Short interest is less than 1% of the free float at roughly…
CSAN3 reports Q1 2026 results today against one of its toughest price backdrops in recent memory. The stock has shed 16% over the past month and nearly 11% in the past week alone, arriving at BRL 4.65 — well below the…
ImmuCell Corporation heads into its Q1 2026 earnings today with short sellers having already voted with their feet — the question is whether the 16% rally over the past month has run ahead of the fundamentals. Short…
Harte Hanks reported Q1 2026 results on May 14, with the numbers landing on the wrong side of expectations — and doing little to disrupt the narrative that shorts had been quietly rebuilding into. Revenue fell to $37.3…
ReposiTrak reported Q3 FY2026 results yesterday after the bell — and the print landed squarely in the middle of a story that had been building for weeks around short positioning, a CEO selling programme, and a stock…
DEFI heads into today's Q1 2026 results with a stock that has already done a lot of the work ahead of the print. The price tells the story most clearly. DEFI closed at CAD 1.12, up 18% on the day prior to the release…
Daily Journal Corporation reported its fiscal Q2 results yesterday, and the headline EPS swing tells the whole story: a loss of $25.14 per share versus earnings of $32.43 a year ago — a reversal entirely explained by…
XPEV heads into its May 18 Q1 earnings call with the lending market under significant stress — short sellers are locked in, availability has nearly vanished, and cost to borrow is climbing fast. The clearest tension is…
Element Solutions Inc heads into its May 18 Q1 earnings call with one clear signal dominating the setup: short sellers have been adding positions at an accelerating pace even as the stock rallies. Short interest has…
Mitsubishi UFJ Financial Group heads into its May 18 earnings with options traders broadly relaxed and short sellers in retreat — a notably unbothered positioning setup for Japan's largest bank. The options market is…
Sumitomo Mitsui Financial Group heads into its May 18 earnings with short sellers building positions at the fastest weekly pace in months — yet the overall setup remains far from crowded. The most notable shift is in…
Credicorp heads into its Q1 2026 results on May 15 with options markets flashing an unusually bullish tilt — the sharpest in more than a year. Options positioning is the standout signal this week. The put/call ratio…
Motorola Solutions heads into its May 18 earnings report with shorts building quickly and options traders leaning bullish — a divergence that makes the setup more interesting than the headline price chart suggests. The…
Dr. Reddy's Laboratories heads into its May 18 earnings call with short sellers at their most active in weeks — and fresh evidence of a significant Q4 stumble already in the market. The short-selling setup is the most…
